Stem cell could be key to chronic kidney disease treatment

Calcification of blood vessels is common among patients with chronic kidney disease. And researchers in St. Louis have found that a type of stem cell causes the clogging and could possibly be fought.

Scientists at the Washington University School of Medicine published a study in the journal Cell Stem Cell that showcases Gli1 positive stem cells as the ones responsible for clogging blood vessels with mineral deposits. They can become any kind of cell from muscle to bone, and in healthy conditions, according to the university, that characteristic can help them heal damaged vessels.

But in chronic kidney disease, the cells become confused and begin to build osteoblasts, which would build bone instead of smooth muscle cells. This would account for the depositing of calcium.

Infographic Download

Reducing Time to Clinic for Your Biomedical Applications

Gelatin methacryloyl (GelMA)-based biomaterials have been widely used in various biomedical research applications due to their suitable biological properties and tunable physical characteristics. Especially over the past 5 years, GelMA-oriented research and patent applications have been growing exponentially, and many of these research concepts are now being translated towards the clinic. Suitable GelMA biomaterials are therefore indispensable to keep pace with the newest medical innovations.

Download to learn more about the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments.

“We expect to find osteoblasts in bone, not blood vessels,” lead researcher Benjamin Humphreys said in a release. “In the mice with chronic kidney disease, Gli1 cells end up resembling osteoblasts, secreting bone in the vessel wall. During kidney failure, blood pressure is high and toxins build up in the blood, promoting inflammation. These cells may be trying to perform their healing role in responding to injury signals, but the toxic, inflammatory environment somehow misguides them into the wrong cell type.”

In mice that had their Gli1 cells removed, the calcification process stopped. So by identifying which cells control the process, the scientists can test ways to block it, Humphreys said. But they don’t want to remove the cells completely from a patient, because they play an important role in healing.

“More recently, we’ve learned that calcification is an active process directed by cells,” Humphreys said in the release. “But there has been a lot of controversy over which cells are responsible and where they come from.”

Suggested Articles

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.

Scientists at the University of Toronto, in collaboration with Agios, identified 182 genes that allow cancer cells to evade the immune system.

UCSD researchers discovered sugar molecules called N-glycans at two sites on SARS-CoV-2 that play an essential role in COVID-19 infection.